Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-396-1 | CAS number: 13770-89-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
A single study was identified characterizing the genotoxicity of nickel sulphamate (tetrahydrate); however, because the primary reference (JETOC 1996) was not able to be obtained, information was based on summary findings presented in the Chemical Carcinogenesis Research Information System (CCRIS 2003) and data provided via personal communication (Okubo T, 2009). Collectively, these secondary sources reported the findings of mutagenicity testing in the Ames Salmonella Typhimurium assay. Results were negative in all six strains tested both in the presence and absence of metabolic activation, with the exception of the metabolically activated E. coli. However, because the documentation was insufficient, these data were not sufficient to characterize the genetic toxicity of nickel sulphamate.
Data regarding genotoxicity of nickel sulphamate are read-across from Ni sulphate. From the data reviewed above there is clear evidence indicating that nickel sulphate is genotoxic in vitro, and in particular, is clastogenic. There are a number of in vivo studies in both animals and man. The study by Benson et al. (2002) is the most comprehensive part of the database onin vivogenotoxicity of Ni compounds and shows that nickel sulphate given by inhalation seems to induce inflammation and genotoxicity in lung cells at approximately the same concentrations. Results of a recent micronucleus study, after oral administration is negative (Oller and Erexson, 2007). Evidence from human studies is limited.
The opinion of the Specialised Experts has been sought with regard to the classification of nickel sulphate as Muta. Cat. 3; R68 at their meeting in April 2004. The Specialised Experts concluded that nickel sulphate, nickel chloride and nickel nitrate should be classified as Muta. Cat. 3; R68. This conclusion is based on evidence of in vivo genotoxicity in somatic cells, after systemic exposure. Hence the possibility that the germ cells are affected cannot be excluded. The Specialised Experts did not consider that further testing of effects on germ cells was practicable (European Commission, 2004).
Further testing in an in vivo comet assay in lung cells after inhalational exposure is also considered to be unnecessary for the purposes of risk characterisation. A positive result would not alter the conclusions for the classification as a mutagen, and a negative result would not be regarded as sufficient evidence to justify the use of a threshold approach in the carcinogenicity risk characterisation. Hence, further testing for this effect would not produce additional information that would significantly change the outcome of this risk assessment.
In addition, bacterial mutagenicity tests have been shown to have little utility for the testing of metals, thus further limiting the usefulness of the available data. Since nickel sulphamate is read across from Ni sulphate it carries a classification as Muta. 2;H341.
The following information is taken into account for any hazard / risk assessment:
Data regarding genotoxicity are read-across from Ni sulphate. There is clear evidence indicating that nickel sulphate is genotoxic in vitro, and in particular, is clastogenic. There are a number of in vivo studies in animals. The study by Benson (2002) shows that nickel sulphate given by inhalation seems to induce inflammation and genotoxicity in lung cells at approximately the same concentrations. Some in vivo studies were positive while a recent repeated dose oral micronucleus study (Oller and Erexson, 2007) was negative. Evidence from human studies is limited. There are no definitive studies on germ cells, and little evidence concerning hereditable effects. Recently, nickel compounds have been recognized as genotoxic carcinogens with threshold mode of action in ECHA RAC opinion on nickel and nickel compounds OELs (see ECHA 2018 report discussion inAppendix C2).
Justification for classification or non-classification
Nickel sulphamate is classified as Muta. 2: H341 in the 1st ATP to the CLP Regulation. Background information regarding this classification is provided in the discussion section above.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.